Pay in 4 interest-free payments of $26.77 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Pharmacology of tolazoline
[Epub ahead of print] PubMed PMID: 27803064
thereby resulting in the increasing Bax/Bcl-2 ratios
CAS Number: 170632-47-0
PI-3065 Catalog No.:M8668-10 Pharmacology of tolazolinePI3065 is a p110 isoform of phosphoinositide 3 OH kinase (PI(3)K) inhibitor. Inhibitors against the p110 isoform of phosphoinositide 3 OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias. As p110 is primarily expressed in leukocytes, drugs against p110 have not been considered for the treatment of solid tumours. p110 inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression.
US$ 20.00
US$ 28.99
US$ 23.92
US$ 11.50
US$ 27.00